The risk of a child dying from a COVID-19 vaccine is far lower than dying in a car accident. COVID-19 vaccines are effective in preventing hospitalizations, urgent care visits and long COVID in ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...

By Michael Erman and Christy Santhosh Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing ...

As you're getting ready to enjoy the holiday season with friends and family, it's important to remember that COVID-19 is still around — but it doesn't need to ruin your festivities. Getting vaccinated ...

Maryland-based Novavax signed a licensing agreement allowing Pfizer access to its technology that boosts immune responses to ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and how that risk might be reduced. They found that the vaccines can spark a two ...

Sanofi's acquisition of Dynavax, valued at $2.2 billion, aims to enhance its vaccine portfolio, including a promising shingles vaccine candidate, Z-1018. Z-1018 has demonstrated comparable ...

WASHINGTON — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients — revving up their immune systems to help fight tumors. People with advanced lung or skin ...

Novavax, the Covid-19 vaccine maker, has licensed the rights for a vaccine-enhancing component to Pfizer. Pfizer agreed to pay $30 million upfront, and could pay up to $500 million more if development ...

TAMPA, Fla. — Florida’s Department of Health is meeting in Panama City Beach on Friday to discuss potential changes to the state’s vaccine requirements, a proposal that could significantly alter which ...

Editor's Note: After this story was published, the CDC said in a press release that Acting Director Jim O'Neill approved the recommendations of the Advisory Committee on Immunization Practices made at ...

COVID-19 infections are rising across the United States, amid surges in other winter illnesses. The uptick in COVID comes as the country faces a severe flu season and outbreaks of norovirus, which are ...